HopeStage
Back to all studies
RecruitingNCT07232641

Buprenorphine and methadone policy changes and treatment access

About this title

Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic

Read the official source — NCT07232641
Observational studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
BostonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 30, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
185,810
Sponsor
Boston University
Sponsor type
University
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT07232641
Official title
Show the full official title

Comparing Treatment Use, Retention, and Patient Outcomes Pre- and Post-implementation of Federal Policy Changes Regulating Buprenorphine and Methadone Treatment for Opioid Use Disorder

Recruitment & locations

Currently recruiting

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Boston University, a university.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies